Intra-Cellular Therapies Inc ITCI
$131.87 $0.05 (0.04%) 1D
Last Updated: Apr 01, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Intra-Cellular Therapies Inc Stock Halal?
Shariah Compliance Analysis of ITCI Stock
Germany Health Care Large Cap No. As of September 2026, Intra-Cellular Therapies Inc (ITCI) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Intra-Cellular Therapies Inc does not pass Musaffa's business and financial screening criteria.
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. The company is headquartered in Bedminster, New Jersey and currently employs 860 full-time employees. The firm leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Company’s product, CAPLYTA (lumateperone), is an oral, once daily atypical antipsychotic approved in adults for the treatment of schizophrenia and the treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate. Its pipeline includes several product candidates in clinical development and additional product candidates in non-clinical testing, such as ITI-1284-ODT-SL program, Phosphodiesterase type I inhibitor (PDE1) program, ITI-333 program, and ITI-1500 Non-Hallucinogenic Psychedelic program. ITI-1284 is a deuterated form of lumateperone, a new chemical entity.
ITCI Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Intra-Cellular Therapies Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Intra-Cellular Therapies Inc (ITCI) Chart
Financial Metrics & Statements of Intra-Cellular Therapies Inc (ITCI)
FAQ's for Intra-Cellular Therapies Inc (ITCI)
- As of September 2026, Intra-Cellular Therapies Inc ITCI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Intra-Cellular Therapies Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Intra-Cellular Therapies Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Intra-Cellular Therapies Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Intra-Cellular Therapies Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Intra-Cellular Therapies Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Intra-Cellular Therapies Inc (ITCI)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
